Unknown

Dataset Information

Hypertension in hemodialysis patients treated with atenolol or lisinopril: a randomized controlled trial.


ABSTRACT:

Background

The purpose of this study was to determine among maintenance hemodialysis patients with echocardiographic left ventricular hypertrophy and hypertension whether in comparison with a β-blocker-based antihypertensive therapy, an angiotensin converting enzyme-inhibitor-based antihypertensive therapy causes a greater regression of left ventricular hypertrophy.

Methods

Subjects were randomly assigned to either open-label lisinopril (n = 100) or atenolol (n = 100) each administered three times per week after dialysis. Monthly monitored home blood pressure (BP) was controlled to <140/90 mmHg with medications, dry weight adjustment and sodium restriction. The primary outcome was the change in left ventricular mass index (LVMI) from baseline to 12 months.

Results

At

SUBMITTER: Agarwal R 

PROVIDER: S-EPMC3938300 | biostudies-literature | 2014 Mar

REPOSITORIES: biostudies-literature